1. Intravenous commercial heparin produces a lymphocytosis in the calf. The effect is not due to the preservative commonly present in heparin.

2. The lymphocytosis is mediated to a great extent by an increased input of lymphocytes into the blood via the thoracic duct.

3. The necessity of considering, plus controlling the heparin effect on blood lymphocyte levels and on the output of thoracic duct lymphocytes in all studies on lymphocyte production, migration and behavior, is discussed and emphasized.

This content is only available as a PDF.
Sign in via your Institution